MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Cassava Sciences Inc

Cerrado

SectorSalud

1.38 0.73

Resumen

Variación precio

24h

Actual

Mínimo

1.34

Máximo

1.41

Métricas clave

By Trading Economics

Ingresos

346K

-28M

BPA

-0.57

Empleados

30

EBITDA

1.4M

-30M

Recomendaciones

By TipRanks

Recomendaciones

Vender

Estimación a 12 meses

+44.93% upside

Dividendos

By Dow Jones

Próximas Ganancias

8 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-40M

80M

Apertura anterior

0.65

Cierre anterior

1.38

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

376 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Cassava Sciences Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

27 sept 2024, 10:48 UTC

Principales Movimientos del Mercado

Cassava Sciences Shares Lower Premarket on $40 Million Penalty to Settle Doctored Data Claims

28 jun 2024, 20:15 UTC

Principales Movimientos del Mercado

Cassava Sciences' Shares Down 46% After Adviser Is Indicted

27 sept 2024, 18:36 UTC

Ganancias

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More -- Barrons.com

27 sept 2024, 09:15 UTC

Acciones populares

Stocks to Watch Friday: Bristol Myers Squibb, EchoStar, Costco -- WSJ

Comparación entre iguales

Cambio de precio

Cassava Sciences Inc Esperado

Precio Objetivo

By TipRanks

44.93% repunte

Estimación a 12 meses

Media 2 USD  44.93%

Máximo 2 USD

Mínimo 2 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Cassava Sciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Vender

2 ratings

0

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

N/A / 1.5Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Neutral Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

376 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.